AF1696
antibody from R&D Systems
Targeting: CD93
C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AF1696 - Provider product page
- Provider
- R&D Systems
- Product name
- Mouse C1qR1/CD93 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified. Detects mouse C1q R1/CD93 in direct ELISAs and Western blots.
- Reactivity
- Mouse
- Host
- Sheep
- Conjugate
- Unconjugated
- Antigen sequence
O89103
- Isotype
- IgG
- Vial size
- 100 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis.
Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist.
Lugano R, Vemuri K, Yu D, Bergqvist M, Smits A, Essand M, Johansson S, Dejana E, Dimberg A
The Journal of clinical investigation 2018 Aug 1;128(8):3280-3297
The Journal of clinical investigation 2018 Aug 1;128(8):3280-3297
Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis.
Greenlee-Wacker MC, Briseño C, Galvan M, Moriel G, Velázquez P, Bohlson SS
Journal of immunology (Baltimore, Md. : 1950) 2011 Sep 15;187(6):3353-61
Journal of immunology (Baltimore, Md. : 1950) 2011 Sep 15;187(6):3353-61
Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist.
Ayers M, Fargnoli J, Lewin A, Wu Q, Platero JS
Cancer research 2007 Jul 15;67(14):6899-906
Cancer research 2007 Jul 15;67(14):6899-906
No comments: Submit comment
No validations: Submit validation data